Le Lézard
Classified in: Health
Subjects: TDS, PET, ANW, FVT

Petco to Participate in the Evercore ISI Virtual Pet Care Summit


SAN DIEGO, Sept. 15, 2023 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced that Brian LaRose, Chief Financial Officer, and Dr. Whitney Miller, DVM, Chief Veterinarian, will participate at the Evercore ISI Virtual Pet Care Summit on September 20, 2023.

Mr. LaRose will participate in a fireside conversation at approximately 11:40 a.m. Eastern Time. Dr. Miller will participate in a panel discussion on pet services at approximately 12:30 p.m. Eastern time.

The webcast of both events will be available via the Company's investor relations page at ir.petco.com. A replay of the webcasts will be archived on the Company's website through October 4, 2023.

About Petco, The Health + Wellness Co.: 

Founded in 1965, Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. We've consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 pet care centers across the U.S., Mexico and Puerto Rico, which offer merchandise, companion animals, grooming, training and a growing network of on-site veterinary hospitals and mobile veterinary clinics. Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app. In tandem with Petco Love, a life-changing organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for nearly 7 million animals.

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical fact. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct. Forward-looking statements are subject to many risks and uncertainties, including the risk factors that Petco identifies in its Securities and Exchange Commission filings, and actual results may differ materially from the results discussed in such forward-looking statements. Petco undertakes no duty to update publicly any forward-looking statement that it may make, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

SOURCE Petco - Investor Relations


These press releases may also interest you

at 08:05
Chrysalis BioTherapeutics today announced it was selected to participate in the 2024 Respiratory Innovation Summit (RIS) at the American Thoracic Society Meeting in San Diego. The Respiratory Innovation Summit (RIS) has been established by the...

at 08:05
Ansa Biotechnologies, Inc., the trusted partner for complex DNA synthesis, today announced that it is expanding its early access program for its complex DNA synthesis services. More customers around the world will now be able to take advantage of the...

at 08:05
Boundless Bio , a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Boundless Bio Chief...

at 08:05
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that 24 month visual acuity results from patients enrolled in a Phase 1/2a clinical study...

at 08:05
Phonak, a leading global provider of life-changing hearing solutions, today announces an FDA cleared self-replacement option for Phonak Lyric, the world's only 100% invisible hearing aid? that provides 24/7 hassle-free hearing? with proven tinnitus...

at 08:05
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Lenti-Xtm Transduction Sponge, a first-to-market dissolvable microfluidic transduction enhancer that innovates in vitro lentivirus-mediated gene...



News published on and distributed by: